UBS Group initiated coverage on shares of UiPath (NYSE:PATH - Free Report) in a report issued on Thursday, MarketBeat.com reports. The firm issued a sell rating and a $14.00 price objective on the stock.
PATH has been the topic of several other research reports. Bank of America upped their price target on UiPath from $16.00 to $18.00 and gave the stock a "neutral" rating in a research note on Friday, September 6th. Morgan Stanley upped their price target on UiPath from $15.00 to $16.00 and gave the stock an "equal weight" rating in a research report on Friday, December 6th. BMO Capital Markets lifted their target price on UiPath from $15.00 to $16.00 and gave the company a "market perform" rating in a research note on Friday, December 6th. Evercore ISI boosted their target price on UiPath from $13.00 to $16.00 and gave the stock an "in-line" rating in a research report on Friday, September 6th. Finally, TD Cowen decreased their price target on shares of UiPath from $17.00 to $16.00 and set a "hold" rating on the stock in a research note on Friday, September 6th. One analyst has rated the stock with a sell rating, sixteen have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $17.50.
Read Our Latest Report on PATH
UiPath Trading Down 2.7 %
Shares of PATH stock traded down $0.40 during midday trading on Thursday, reaching $14.24. 8,166,223 shares of the stock were exchanged, compared to its average volume of 9,697,685. UiPath has a 1 year low of $10.37 and a 1 year high of $27.87. The firm has a market cap of $7.83 billion, a PE ratio of -89.00 and a beta of 0.94. The company's 50 day moving average is $13.25 and its two-hundred day moving average is $12.69.
Insider Activity at UiPath
In other news, CFO Ashim Gupta sold 47,671 shares of the stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $12.07, for a total transaction of $575,388.97. Following the transaction, the chief financial officer now directly owns 849,917 shares in the company, valued at approximately $10,258,498.19. This trade represents a 5.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 22.37% of the stock is owned by company insiders.
Institutional Investors Weigh In On UiPath
A number of institutional investors have recently added to or reduced their stakes in the stock. Ontario Teachers Pension Plan Board grew its stake in shares of UiPath by 136.0% during the third quarter. Ontario Teachers Pension Plan Board now owns 108,725 shares of the company's stock worth $1,392,000 after acquiring an additional 62,650 shares during the last quarter. D.A. Davidson & CO. grew its position in UiPath by 60.1% during the 3rd quarter. D.A. Davidson & CO. now owns 557,667 shares of the company's stock worth $7,138,000 after purchasing an additional 209,300 shares during the period. Senvest Management LLC raised its position in UiPath by 16.7% during the third quarter. Senvest Management LLC now owns 10,894,483 shares of the company's stock valued at $139,449,000 after acquiring an additional 1,559,500 shares in the last quarter. Quantbot Technologies LP increased its holdings in shares of UiPath by 667.7% during the 3rd quarter. Quantbot Technologies LP now owns 101,718 shares of the company's stock valued at $1,302,000 after purchasing an additional 88,468 shares in the last quarter. Finally, LMR Partners LLP acquired a new position in shares of UiPath in the third quarter worth about $561,000. Institutional investors own 62.50% of the company's stock.
About UiPath
(
Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Stories
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.